Developer of a diagnostic platform designed to facilitate noninvasive disease monitoring through bio-marker technology. The company’s platform utilizes precisely engineered diagnostic agents that interrogate the body for certain disease states and then carry the message to the urine for analysis, enabling physicians to use noninvasive and predictive monitoring of multiple human diseases like certain cancers, blood-clotting diseases and fibrosis of the liver faster and more accurately than currently available bio-marker technologies.

Glympse Bio Website